Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-096010
Filing Date
2011-11-07
Accepted
2011-11-07 17:01:08
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q c24156e10vq.htm 10-Q 184772
2 EXHIBIT 31.1 c24156exv31w1.htm EX-31.1 9179
3 EXHIBIT 31.2 c24156exv31w2.htm EX-31.2 9458
4 EXHIBIT 32.1 c24156exv32w1.htm EX-32.1 4132
  Complete submission text file 0000950123-11-096010.txt   1138333

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT cpix-20110930.xml EX-101.INS 86290
6 EX-101 SCHEMA DOCUMENT cpix-20110930.xsd EX-101.SCH 9326
7 EX-101 CALCULATION LINKBASE DOCUMENT cpix-20110930_cal.xml EX-101.CAL 30389
8 EX-101 LABELS LINKBASE DOCUMENT cpix-20110930_lab.xml EX-101.LAB 113319
9 EX-101 PRESENTATION LINKBASE DOCUMENT cpix-20110930_pre.xml EX-101.PRE 72843
10 EX-101 DEFINITION LINKBASE DOCUMENT cpix-20110930_def.xml EX-101.DEF 9244
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 111185314
SIC: 2834 Pharmaceutical Preparations